DalsnaFinance

Repligen beefs up cell therapy business with $1.5 billion deal for BioLife

Markets Reuters By Reuters 22 Jul 2026 13:47 1 min read
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife

Repligen beefs up cell therapy business with $1.5 billion deal for BioLife  Reuters

Repligen beefs up cell therapy business with $1.5 billion deal for BioLife Reuters

Read the full story on Reuters → Opens the original article on news.google.com

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.